Tiens Biotech Group (USA) Reports Second Quarter and Six-Mon...(572767 538130 Deferred inc...)

Deferred income 5,210,120 4,895,049

Total non current liabilities 8,985,629 9,700,921

Total liabilities 42,012,449 42,445,681

MINORITY INTEREST 8,484,637 6,144,063

SHAREHOLDERS' EQUITY:

Common stock, $0.001 par value,

250,000,000 shares authorized,

71,333,586 issued and outstanding,

respectively 71,334 71,334

Paid-in-capital 8,842,009 8,842,009

Statutory reserves 9,420,783 9,420,783

Retained earnings 86,918,663 78,668,160

Accumulated other comprehensive income 23,059,672 15,960,044

Total shareholders' equity 128,312,461 112,962,330

Total liabilities and

shareholders' equity $ 178,809,547 $ 161,552,074

TIENS BIOTECH GROUP (USA), INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE SIX MONTHS ENDED JUNE 30, 2008 AND 2007 (UNAUDITED)

June 30, June 30,

2008 2007

As Adjusted

(Note 1)

CASH FLOWS FROM OPERATING ACTIVITIES:

Net Income $ 8,250,503 $ 11,512,659

Adjustments to reconcile net income

to cash provided by (used in)

operating activities:

Provision for doubtful accounts 37,715 547

Minority interest 1,887,079 3,122,579

Depreciation
'/>"/>